EFS
IBB icon

Essex Financial Services’s iShares Biotechnology ETF IBB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$848K Hold
6,704
0.06% 293
2025
Q1
$857K Sell
6,704
-254
-4% -$32.5K 0.06% 259
2024
Q4
$920K Sell
6,958
-15
-0.2% -$1.98K 0.07% 250
2024
Q3
$1M Sell
6,973
-1,218
-15% -$175K 0.07% 241
2024
Q2
$1.16M Buy
8,191
+1,146
+16% +$163K 0.09% 208
2024
Q1
$967K Buy
7,045
+580
+9% +$79.6K 0.09% 213
2023
Q4
$878K Sell
6,465
-435
-6% -$59.1K 0.09% 214
2023
Q3
$844K Hold
6,900
0.1% 197
2023
Q2
$876K Sell
6,900
-25
-0.4% -$3.17K 0.1% 194
2023
Q1
$894K Sell
6,925
-168
-2% -$21.7K 0.09% 196
2022
Q4
$931K Sell
7,093
-144
-2% -$18.9K 0.1% 188
2022
Q3
$846K Sell
7,237
-120
-2% -$14K 0.1% 183
2022
Q2
$865K Sell
7,357
-835
-10% -$98.2K 0.1% 198
2022
Q1
$1.07M Buy
8,192
+72
+0.9% +$9.38K 0.1% 193
2021
Q4
$1.24M Buy
8,120
+360
+5% +$54.9K 0.12% 169
2021
Q3
$1.26M Buy
7,760
+1,175
+18% +$190K 0.14% 155
2021
Q2
$991K Hold
6,585
0.14% 151
2021
Q1
$991K Buy
6,585
+362
+6% +$54.5K 0.18% 129
2020
Q4
$943K Buy
6,223
+1,541
+33% +$234K 0.19% 119
2020
Q3
$634K Buy
4,682
+980
+26% +$133K 0.16% 130
2020
Q2
$506K Buy
3,702
+190
+5% +$26K 0.16% 130
2020
Q1
$378K Buy
3,512
+1,349
+62% +$145K 0.13% 151
2019
Q4
$261K Buy
+2,163
New +$261K 0.07% 227
2018
Q2
Sell
-6,141
Closed -$656K 305
2018
Q1
$656K Buy
+6,141
New +$656K 0.13% 165
2017
Q3
Sell
-1,053
Closed -$327K 304
2017
Q2
$327K Buy
1,053
+158
+18% +$49.1K 0.07% 256
2017
Q1
$262K Sell
895
-26
-3% -$7.61K 0.06% 270
2016
Q4
$244K Buy
921
+153
+20% +$40.5K 0.05% 273
2016
Q3
$222K Buy
+768
New +$222K 0.05% 274
2016
Q2
Sell
-1,813
Closed -$473K 310
2016
Q1
$473K Sell
1,813
-1,119
-38% -$292K 0.12% 176
2015
Q4
$992K Sell
2,932
-90
-3% -$30.5K 0.24% 104
2015
Q3
$917K Sell
3,022
-65
-2% -$19.7K 0.24% 102
2015
Q2
$1.14M Buy
3,087
+205
+7% +$75.6K 0.29% 85
2015
Q1
$990K Buy
2,882
+405
+16% +$139K 0.25% 103
2014
Q4
$751K Buy
2,477
+260
+12% +$78.8K 0.2% 127
2014
Q3
$607K Buy
2,217
+489
+28% +$134K 0.18% 139
2014
Q2
$444K Buy
1,728
+95
+6% +$24.4K 0.13% 176
2014
Q1
$386K Buy
+1,633
New +$386K 0.13% 179